T80.810A Extravasation of vesicant antineoplastic chemotherapy, initial encounter
ICD10CM code
ICD10CM
Name of the Condition
Extravasation of Vesicant Antineoplastic Chemotherapy, Initial Encounter
Also known as chemotherapy extravasation.
Summary
This condition occurs when a vesicant chemotherapy drug leaks from a blood vessel into surrounding tissues. Vesicants are highly irritating drugs that can cause severe tissue damage when not administered properly.
Causes
Most commonly caused during intravenous (IV) administration of highly concentrated chemotherapy drugs where the drug leaks out of the vein.
Risk Factors
High-risk factors include small veins, fragile veins often found in elderly patients, repeated cannulations, prior damage to veins from previous treatments, and inexperienced healthcare personnel administering chemotherapy.
Symptoms
Patients may experience pain, swelling, redness, or a burning sensation at the site of the IV injection. If severe, there might be tissue necrosis leading to ulceration.
Diagnosis
Diagnosis is primarily based on clinical examination and patient history. Imaging tests such as ultrasound might be used to assess the extent of the leakage and damage.
Treatment Options
Immediate cessation of the infusion of the drug.
Application of ice or heat packs, depending on the protocol for the specific drug.
Administration of antidotes or medications to neutralize the drug.
Surgical interventions might be necessary in severe cases to remove dead tissue.
Prognosis and Follow-Up
With prompt treatment, the prognosis is generally good, but late treatment may lead to long-term complications like scarring.
Follow-up involves monitoring for any signs of infection or delayed healing.
Complications
Potential complications include severe tissue necrosis, compartment syndrome, nerve damage, and chronic pain at the site of extravasation if not promptly treated.
Lifestyle & Prevention
Preventive measures in hospital settings include careful administration techniques, using freshly skilled personnel to administer vesicants, and monitoring of infusion sites.
Patients and caregivers should be educated to report any discomfort immediately during chemotherapy infusions.
When to Seek Professional Help
Immediate attention is needed if you experience severe pain, swelling, blistering, or discoloration around the IV site during or after chemotherapy administration.